Researchers from The University of Texas MD Anderson Cancer Center; The University of Texas Southwestern Medical Center in Dallas; and the Chinese Academy of Sciences in China have discovered that certain nanotechnology-based cancer therapies may be less effective in younger patients, highlighting the need for further investigation into the impact of aging on the body's ability to respond to treatment. The researchers found age-related differences are due to how effectively the liver filters the bloodstream. Younger livers are more efficient at this process, which helps limit toxins in the blood but also filters out beneficial treatments, potentially rendering them ineffective.
An official website of the United States government.